Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford is delighted to announce a joint gift from the Eurofins Foundation and SENSE Foundation Brussels to support students in the Medical Sciences and Mathematical, Physical and Life Sciences Divisions. The donation will lead to the creation of Eurofins Awards for undergraduate and postgraduate students, which will be granted over the course of the next three years.

© John Cairns
Analysing volatile samples using a Gas Chromatography Mass Spectronomy System

The Eurofins Awards will provide students with the opportunity to travel overseas for field trips, research or training, and will also support dissertation writing costs. This will enable more students to undertake extra-curricular activities that will enhance their studies and benefit them as they take the first steps in their professional lives. The awards will be made available to academically outstanding students who would not otherwise be able undertake such activities.

Professor Robert Gilbert, Director of the Graduate School in the Medical Sciences Division, says: ‘We are extremely grateful to the Eurofins Foundation and SENSE Foundation Brussels for their support of students in the Medical Sciences. These awards will help our students gain valuable, additional experience to support their professional development and ensure that they make the most of all opportunities whilst studying here.’

Read more on the University of Oxford's Development Office website

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

20 minutes of daily exercise can keep teens' doctors away

Teenagers should exercise vigorously for at least 20 minutes per day to reap increased cardiorespiratory fitness (CRF), according to a cross-sectional study from the UK led by University of Oxford researchers.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.